Results 81 to 90 of about 2,854 (189)

Genetic Basis of the Negative Response to the Use of Triptans for the Treatment of Migraine—A Systematic Review and Meta‐Analysis

Brain and Behavior
Introduction Migraine is a widespread and disabling neurological disorder, and triptans are a primary treatment for acute episodes. However, around 40% of patients are non‐responsive.
Victoria Gomes Andreata, Ruan Pablo Duarte Freitas, Jéssica da Silva Nascimento, Patrícia Sodré Araújo, Felipe Eustáquio dos Santos Guedes, João Vítor Benjamim Pires, Narel Moita Carneiro Nogueira Falcão, Natasha da Silva Leitão, Alcylene Carla de Jesus dos Santos, Ana Patrícia Pascoal Queiroz, Astria Ferrão Dias Gonzales, Maica Matos Leão, Emília Katiane Embiruçu de Araújo Leão, Juliana Côrtes Freitas, Acássia Benjamim Leal Pires   +14 more
doaj   +1 more source

Tryptamine receptors [PDF]

The Journal of Physiology, 1953
openaire   +2 more sources

EFFECT OF TRYPTAMINE AND TRYPTAMINE HOMOLOGUES ON CEREBRAL ELECTRICAL ACTIVITY AND BEHAVIOUR IN THE CAT [PDF]

British Journal of Pharmacology and Chemotherapy, 1965
P B, BRADLEY, E, MARLEY
openaire   +2 more sources

TRYPTAMINE RECEPTORS AND TYRAMINE

Japanese Journal of Pharmacology, 1966
CHANDRA, OM, DHAWAN, K.N., GUPTA, G.P., SAXENA, P.R.   +3 more
openaire   +3 more sources

Psychedelic Drugs Rediscovered-In Silico Study of Potential Fetal Exposure to Analogues of Psychedelic Drugs During Pregnancy. [PDF]

Molecules
Sobańska AW, Sobański AM, Brzezińska E.   +2 more
europepmc   +1 more source

Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine and Related Analogs. [PDF]

ACS Chem Neurosci
Glatfelter GC, Schalk SS, Walther D, Maitland AD, Gonzalez NR, Partilla JS, Anas NA, Chadeayne AR, Naeem M, Manke DR, McCorvy JD, Baumann MH.   +11 more
europepmc   +1 more source

Triptans for Migraine: Balancing Potential Vascular Risk With Meaningful Benefit

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Anders Hougaard
doaj   +1 more source

Monitoring of new psychoactive substances in France: update of addictovigilance data. [PDF]

Eur J Public Health
Autellet A, Lacroix C, Batisse A, Micallef J, Fouilhe N, Le Boisselier R, Peyrière H, Eiden C, French Addictovigilance Network .   +8 more
europepmc   +1 more source

Enzymatic aminolysis in continuous flow: an efficient strategy for the synthesis of salicylamide derivatives. [PDF]

RSC Adv
Du LH, Xue MM, Yan BL, Wang L, Luo XP.
europepmc   +1 more source

Explainable Artificial Intelligence (xAI) for 5-HT_2A Receptor Binding Affinity of New Psychoactive Substances. [PDF]

Molecules
Schöning V, Grafinger KE, Pasin D, Stove CP, Weinmann W, Hammann F.   +5 more
europepmc   +1 more source